13 Penny Stocks with Insider Buying in 2024
In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks...
Corvus Pharmaceuticals Inc. (CRVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,943,654 | $12,359,704 | 0.22% | |
| 2. | Adams Street Partners Jeffrey Diehl | 3,275,616 | $5,830,596 | 2.31% | |
| 3. | Samlyn Capital Robert Pohly | 2,348,363 | $4,180,086 | -6% | 0.06% |
| 4. | Biotechnology Value Fund / BVF Inc Mark Lampert | 361,406 | $643,303 | -74% | 0.01% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 185,100 | $329,478 | -22% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.73 | 20,000 | 153,773 | 2024-05-06 | Filing | ||
| $1.73 | 577,634 | 577,634 | 2024-05-06 | Filing | ||
| $2.45 | 10,000 | 10,000 | 2023-05-15 | Filing | ||
| $0.79 | 20,000 | Officer | 133,773 | 2022-12-20 | Filing | |
| $0.84 | 4,000 | Officer | 133,238 | 2022-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.96 | 2,000,000 | Large Shareholder | 81,077 | 2021-10-01 | Filing | |
| $5.04 | 3,000,000 | Large Shareholder | 2,081,077 | 2021-09-30 | Filing | |
| $6.09 | 1,109,644 | Large Shareholder, Director | 6,943,654 | 2021-09-20 | Filing | |
| $6.09 | 1,109,644 | Large Shareholder, Director | 6,943,654 | 2021-09-20 | Filing | |
| $5.37 | 741,440 | Large Shareholder | 1,389,498 | 2020-07-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,350,633 | $2,377,114 | 0% | |
| 2. | 520,551 | $916,170 | 0% | |
| 3. | 436,873 | $768,896 | 0.46% | |
| 4. | 360,380 | $634,410 | 0% | |
| 5. | 259,655 | $456,992 | 0% |
News See All
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript
Operator: Good afternoon ladies and gentlemen and welcome to the Corvus Pharmaceuticals' Business Update and Reports First Quarter 2024 Financial Results Conference Call.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript
Corvus Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.14 EPS, expectations were $-0.14.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2023 Business Update and Financial Results Conference Call.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the Corvus Pharmaceuticals Second Quarter 2023 Conference Call. [Operator Instructions].
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen.
10 Best Stocks to Buy Now According to Jeffrey Diehl's Adams Street Partners
In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl.
Top 10 Stock Picks of Jeffrey Diehl's Adams Street Partners
In this article, we will be taking a look at the top 10 stock picks of Jeffrey Diehl's Adams Street Partners.
Why These 5 Stocks Are On the Move on Friday
5. United States Steel Corporation (NYSE:X) is around 8% lower today after the company provided a third quarter update.
Hedge Fund and Insider Trading News: Warren Buffett, Bill Ackman, Ken Griffin, Crispin Odey, Anthony Scaramucci, Corvus Pharmaceuticals Inc (CRVS), Carnival Corp (CCL), and More
A historic economic comeback is sending some of the world’s biggest investors bargain hunting in the unloved energy sector.
Billionaire Hedge Funds
